![]() |
Inflammatory Bowel Diseases |
Free Subscription
1 Aliment Pharmacol Ther |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Inflammatory Bowel Diseases is free of charge.
The Effectiveness of Medical Therapies for Joint, Skin and Eye Extraintestinal
Manifestations in IBD-An Umbrella Review.
Aliment Pharmacol Ther. 2025;61:1854-1871.
PubMed
Abstract available
Listening Beyond the Symptoms: Existential Needs and Identity in Older Adults
With Inflammatory Bowel Disease.
Am J Gastroenterol. 2025 May 27. doi: 10.14309/ajg.0000000000003514.
PubMed
Association between the immune-inflammation index and the severity and clinical
outcomes of patients with inflammatory bowel disease: a systematic review and
meta-analysis.
BMC Gastroenterol. 2025;25:414.
PubMed
Abstract available
Epidemiology of Elderly Onset IBD: A Nationwide Population-Based Cohort Study.
Clin Gastroenterol Hepatol. 2025;23:1204-1215.
PubMed
Abstract available
A Comprehensive Review of Geriatric Syndromes and Assessment in Older Adults With
Inflammatory Bowel Diseases.
Clin Gastroenterol Hepatol. 2025;23:1088-1101.
PubMed
Abstract available
Exploring infliximab serum level variability in inflammatory bowel disease:
Comprehensive analysis of patient subgroups and treatment outcomes "Infliximab
trough levels variability in inflammatory bowel disease".
Gastroenterol Hepatol. 2025 May 23:502472. doi: 10.1016/j.gastrohep.2025.502472.
PubMed
Abstract available
Skin lesions and chest pain in a patient with Crohn's disease.
Gut. 2025 May 24:gutjnl-2025-335547. doi: 10.1136/gutjnl-2025-335547.
PubMed
Emerging manifestations of IL-17 immunomodulation in the gastrointestinal tract.
Hum Pathol. 2025;158:105782.
PubMed
Abstract available
Rectal and Rectosigmoid Endoscopy to Assess Endoscopic and Histological Remission
in Ulcerative Colitis: A Prospective Study.
Inflamm Bowel Dis. 2025 May 24:izaf094. doi: 10.1093.
PubMed
Abstract available
Plasma Calprotectin and Myeloperoxidase as Biomarkers in Inflammatory Bowel
Disease.
Inflamm Bowel Dis. 2025 May 24:izaf110. doi: 10.1093.
PubMed
Abstract available
Myeloperoxidase Enzyme Activity in Feces Reflects Endoscopic Severity in
Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2025 May 24:izaf109. doi: 10.1093.
PubMed
Abstract available
Incidence and Risk Factors for Development of Acne (JAKne) in Patients with
Inflammatory Bowel Disease Treated With Upadacitinib.
Inflamm Bowel Dis. 2025 May 24:izaf115. doi: 10.1093.
PubMed
Intraoperative Autologous Platelet-Rich Stroma Injection as Add-On to Fistula
Curettage and Closure of the Internal Orifice Demonstrates a Favorable Outcome in
Long-Term in Patients Suffering from Therapy-Refractory Perianal Fistulizing
Crohn's Diseas
Inflamm Bowel Dis. 2025 May 24:izaf011. doi: 10.1093.
PubMed
Abstract available
High Rate of Seroprotection With Heplisav-B in Patients With Inflammatory Bowel
Disease.
J Clin Gastroenterol. 2024 Nov 6. doi: 10.1097/MCG.0000000000002098.
PubMed
Abstract available
Obefazimod in Patients with Moderate-to-Severely Active Ulcerative Colitis:
Efficacy and Safety Analysis from the 96-week Open-label Maintenance Phase 2b
study.
J Crohns Colitis. 2025 May 26:jjaf074. doi: 10.1093.
PubMed
Abstract available
Spatial Immune Profiling of Crohn's Disease Fistula Carcinomas - Defining a
Distinct Cancer Subtype.
J Crohns Colitis. 2025 May 26:jjaf086. doi: 10.1093.
PubMed
Abstract available
Therapeutic potential of Janus kinase inhibitors for the management of fibrosis
in inflammatory bowel disease.
J Crohns Colitis. 2025 May 24:jjaf087. doi: 10.1093.
PubMed
Abstract available
Heat shock transcription factor 2 reduces mitochondrial pathway apoptosis in
intestinal epithelial cells by inhibiting the increase in mitochondrial membrane
permeability in ulcerative colitis.
PLoS One. 2025;20:e0325275.
PubMed
Abstract available
Correction: Profound gene expression changes in the epithelial monolayer of
active ulcerative colitis and Crohn's disease.
PLoS One. 2025;20:e0325481.
PubMed
Abstract available
Engineering a protease-stable, oral single-domain antibody to inhibit IL-23
signaling.
Proc Natl Acad Sci U S A. 2025;122:e2501635122.
PubMed
Abstract available
Increased mucosal and T-cell expression of 4-1BB and PD-1 are modulated by
anti-TNFalpha treatment in Crohn's disease.
Scand J Gastroenterol. 2025 May 24:1-9. doi: 10.1080/00365521.2025.2505622.
PubMed
Abstract available
Thank you for your interest in scientific medicine.